June 16, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
U.S. pharmacy organizations are advocating for the use of the 2021 race-neutral CKD-EPI equation for “medication-related decisions,” according to a consensus statement. In conjunction with the National Kidney Foundation, pharmacy organizations wrote that the race-neutral CKD-EPI, as opposed to the Cockcroft-Gault estimated creatinine clearance equation, should be the “preferred creatinine-only
June 16, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Implementation of a race-neutral eGFR equation contributed to more than 20,000 wait-time modifications and more kidney…

About 36 million U.S. adults have chronic kidney disease, with increasing prevalence tied to diabetes, according to study data…

Recent data reveal a striking paradox: While 73% of endocrinologists prescribe glucose-lowering medications, fewer than 10% of…

PHILADELPHIA — With combination therapies and multiple treatment options available for patients, nephrology is in a “therapeutic…

When comparing associations with mortality, combined creatinine-cystatin C assessment was more comparable to measured GFR than…

National Kidney Foundation Workshop Identifies Major Gaps in Gout Treatment and Chronic Kidney Disease Care